Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04165850
What this trial is testing

Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisALS
NeuroSense Therapeutics Ltd. 16
Not applicableStudy completedNCT00718497
What this trial is testing

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 25
Testing effectiveness (Phase 2)Study completedNCT00397423
What this trial is testing

G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University 40
Not applicableUnknownNCT06169696
What this trial is testing

EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis

Who this might be right for
Neurologic DisorderParalysisParalysis; Stroke+5 more
Synaptrix Labs Inc. 6
Testing effectiveness (Phase 2)Study completedNCT01884571
What this trial is testing

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Emory University 31
Not applicableWithdrawnNCT03664206
What this trial is testing

Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance Spectroscopy

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron DiseaseCortical Excitability
Sándor Beniczky
Early research (Phase 1)Active Not RecruitingNCT05695521
What this trial is testing

Regulatory T Cells for Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Cellenkos, Inc. 66
Testing effectiveness (Phase 2)WithdrawnNCT00561366
What this trial is testing

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
CytRx
Not applicableUnknownNCT01530438
What this trial is testing

Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Caen 90
Testing effectiveness (Phase 2)Study completedNCT00409721
What this trial is testing

The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Alberta 42
Early research (Phase 1)Not Yet RecruitingNCT06704347
What this trial is testing

Safety Study of XT-150 in Participants With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Xalud Therapeutics, Inc. 8
Not applicableLooking for participantsNCT06649955
What this trial is testing

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Who this might be right for
ALS - Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00919555
What this trial is testing

Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Phoenix Neurological Associates, LTD 28
Not applicableWithdrawnNCT05830214
What this trial is testing

Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisMuscular Atrophy, Progressive+2 more
University of Alberta
Not applicableNo Longer AvailableNCT04309604
What this trial is testing

IC14 for ALS Patients Expanded Access

Who this might be right for
Amyotrophic Lateral Sclerosis
Implicit Bioscience
Large-scale testing (Phase 3)Study completedNCT00876772
What this trial is testing

Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Charite University, Berlin, Germany 40
Not applicableUnknownNCT04918251
What this trial is testing

EEG and TMS-based Biomarkers of ALS, MS and FTD

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaMultiple Sclerosis
University of Dublin, Trinity College 400
Testing effectiveness (Phase 2)Study completedNCT02794857
What this trial is testing

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuraltus Pharmaceuticals, Inc. 138
Not applicableUnknownNCT04328675
What this trial is testing

Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 4,752
Testing effectiveness (Phase 2)UnknownNCT01494480
What this trial is testing

The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
General Hospital of Chinese Armed Police Forces 30
Next Page